TRIPHASIL


Tablet
scheduling status
S3
registration number
N/18.8/0040
What TRIPHASIL contains
TRIPHASIL contains six (6) brown active sugar-coated tablets, five (5) white active sugar-coated tablets, ten (10) yellow active sugar-coated tablets and seven (7) red placebo sugar-coated tablets. Each brown active sugar-coated tablet of TRIPHASIL contains 50 µg of levonorgestrel and 30µg of ethinyl estradiol. Each white active sugar-coated tablet of TRIPHASIL contains 75 µg of levonorgestrel and 40 µg of ethinyl estradiol. Each yellow active sugar-coated tablet of TRIPHASIL contains 125 µg of levonorgestrel and 30 µg of ethinyl estradiol. Each red placebo sugar-coated tablet of TRIPHASIL contains sugar: Lactose monohydrate 38,006 mg, sucrose 24,599 mg. Preservative: Sodium benzoate 0,002 % m/m.
other ingredients
Brown active tablets: Calcium carbonate light, iron oxide red (C.I. 77492), iron oxide yellow (C.I. 77491), lactose monohydrate, magnesium stearate, methyl paraben, polyethylene glycol, povidone, propyl paraben, sucrose, starch maize, talc purified, titanium dioxide (C.I. No: 77891), Waradur XE. White active tablets: Calcium carbonate light, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, sucrose, starch maize, talc purified, Waradur XE. Yellow active tablets: Calcium carbonate light, iron oxide red (C.I. 77492), iron oxide yellow (C.I. 77491), lactose monohydrate, magnesium stearate, methyl paraben, polyethylene glycol, povidone, propyl paraben, sucrose, starch maize, talc purified, titanium dioxide (C.I. No: 77891), Waradur XE. Red placebo tablets: Calcium carbonate light, FD&C Red No. 3 Lake (C. I. 45430), FD&C Yellow 6 (C.I. 15985), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, Ponceau 4R Aluminium Lake (C. I. 16255), povidone.
Therapeutic classification
G03AB03 (A 18.8 Ovulation controlling agents).
© 2026 SAHPRA. ALL RIGHTS RESERVED